Polydex Pharmaceuticals Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a POLXF research report →
About the company
Polydex Pharmaceuticals Limited (PPL), a Toronto, Canada-based company, was incorporated in 1979 and initially operated as Polydex Chemicals Limited before adopting its current name in March 1984. PPL specializes in the research, development, manufacturing, and global marketing of biotechnology-derived products for the human pharmaceutical sector. Beyond its human health focus, PPL also produces vital pharmaceutical intermediates for the veterinary industry.
- CEO
- George G. Usher
- IPO
- 1983
- Employees
- 20
- HQ
- Toronto, ON, CA
Price Chart
- Market Cap
- $6.82M
- P/E
- -2.76
- P/S
- 1.52
- P/B
- 1.76
- EV/EBITDA
- -10.66
- Div Yield
- 0.00%
- Gross Margin
- -2.05%
- Op Margin
- -26.23%
- Net Margin
- -49.08%
- ROE
- -53.04%
- ROIC
- -25.50%
- Revenue
- $4.48M · -7.12%
- Net Income
- $-2,199,358 · -38.20%
- EPS
- $-0.72 · -38.46%
- Op Income
- $-1,175,609
- FCF YoY
- -113.98%
- 52W High
- $2.01
- 52W Low
- $0.55
- 50D MA
- $1.93
- 200D MA
- $1.07
- Beta
- 0.45
- Avg Volume
- 5.53K
Get TickerSpark's AI analysis on POLXF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our POLXF coverage
Recent articles, reports, and earnings notes.
No research on POLXF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate POLXF report →Similar companies
Peers in the same neighborhood.